Translate this page into:
Patient Involvement in Medication Safety at a Tertiary Care Teaching Hospital

*Corresponding author: Salman Ahmed Syed, Department of Hospital Administration, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India. drsalman91@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Syed SA, Reddy KV, Zeeshanuddin M, Satyanarayana N. Patient Involvement in Medication Safety at a Tertiary Care Teaching Hospital. Glob J Med Pharm Biomed Update. 2025;20:18. doi: 10.25259/GJMPBU_37_2025
Abstract
Objectives:
Patient involvement enhances safety, quality, and patient-centeredness in healthcare by empowering patients, families, and caregivers to participate in care processes actively. Encouraging patients to monitor and update medication plans can improve treatment adherence and enable timely interventions. This study investigates inpatient engagement in medication safety behaviours, their desire for involvement, and healthcare professional support at a tertiary care teaching hospital.
Material and Methods:
Using quantitative questionnaires (Inpatient Medication Safety Involvement Scale and Control Preference Scale) with 100 patients and 100 healthcare professionals, the study found strong support for patient involvement, particularly among professionals.
Results:
However, a significant gap exists between patients’ desired and actual engagement, with systemic barriers hindering progress. Both groups favoured shared decision-making, though patients leaned toward doctor-led decisions.
Conclusion:
Interventions like patient education and professional training are needed to bridge this gap and enhance safety.
Keywords
Control preference scale
Inpatient medication safety involvement scale
Medication safety
Patient involvement
INTRODUCTION
Patient involvement is a cornerstone of modern health care, emphasizing the active participation of patients, families, caregivers, and healthcare providers to enhance safety, quality, and patient-centeredness. Engaging patients in managing their medication plans improves treatment adherence and enables providers to monitor and intervene as needed, aligning with the World Health Organization’s (WHO) framework for patient safety, which emphasizes systems to minimize risks and prevent harm.[1] Patient safety remains a critical component of healthcare quality, with global efforts like the WHO’s World Alliance for Patient Safety addressing persistent challenges due to systemic issues and human factors. The Institute of Medicine highlights medical errors as a significant contributor to mortality, though comparisons require cautious interpretation due to methodological variations.[2]
Inpatient medication safety activities, such as reviewing medication records, preventing dose omissions, providing information during shift handovers, and raising concerns, are vital for reducing errors. While numerous strategies exist, few have demonstrated substantial impact.[3] Increasing patient involvement in inpatient medication management is a promising yet underexplored approach. Patients often possess critical knowledge about their pre-admission medications, serving as a safeguard against errors. A 2018 systematic review by Kim et al. found that patient education and medication reconciliation reduced errors, though engagement was limited by barriers such as insufficient awareness or lack of provider encouragement.[4] Local observations indicate patients occasionally prevent errors by questioning medications, but confusion about inpatient prescriptions often hinders participation.[5]
This study explores patient and healthcare professional preferences for inpatient engagement in medication safety behaviours and decision-making, aiming to identify gaps and opportunities for improvement in a tertiary care teaching hospital.
Aim of the study
This study aims to examine the preferences of patients and healthcare professionals regarding inpatient engagement in medication safety behaviours and their preferences for medication-related decision-making.
Objectives
To assess patients’ preferences and actual involvement in medication-related activities during hospitalization
To evaluate healthcare professionals’ support for patient involvement in medication-related activities
To compare patient and healthcare professional perspectives on medication involvement
To measure preferences for decision-making involvement regarding medications among patients and healthcare professionals.
MATERIAL AND METHODS
Study design
An exploratory analytical study was conducted using quantitative questionnaires to capture perspectives of patients and healthcare professionals in a tertiary care teaching hospital.
Sample size
The study included 100 patients and 100 healthcare professionals (50 doctors and 50 nurses), selected via convenience sampling from various hospital wards, allowing exploratory comparisons across gender, age, and professional groups.
Instruments
Two tailored quantitative questionnaires were developed:
Inpatient medication safety involvement scale: Adapted from Mohsin-Shaikh et al.,[6] the patient version included eight questions exploring views and experiences with medication safety, while the healthcare professional version had five questions focusing on their perspectives.
Control preference scale: Adapted by Mohsin-Shaikh et al.,[6] this validated instrument assessed preferences for involvement in medication-related decision-making.
Additional questions captured demographic data (gender, age, and profession for healthcare professionals).
Data collection
Conducted from July 2024 to December 2024, the questionnaire responses were collected across hospital wards. Patients were selected based on their ability to read and understand medication charts to ensure meaningful responses. To protect patient privacy, questionnaires were anonymized, and data were stored securely in compliance with institutional data protection protocols, with access restricted to the research team.
Data analysis
Data were analyzed descriptively using percentages and frequency distributions. Statistical tests (Wilcoxon signed-rank test, Mann–Whitney U-test, and Chi-square test) identified significant differences between groups.
Ethics
The study received approval from the institutional ethics committee, and informed consent was obtained from all participants.
RESULTS
Responses were gathered from 100 patients and 100 healthcare professionals (50 doctors and 50 nurses) across various wards. Demographic details are summarized in Table 1.
| Group | Number | Age range | Gender (M/F) |
|---|---|---|---|
| Patients | 100 | 18–75 | 52/48 |
| Healthcare professionals | 100 | 25–60 | 45/55 |
| Doctors | 50 | 28–60 | 30/20 |
| Nurses | 50 | 25–55 | 15/35 |
Patient involvement gaps
Figure 1 and Table 2 illustrates a significant gap between patients’ actual and desired involvement in medication safety behaviours. For example, only 43% of patients reviewed their medication administration records, yet 79% expressed a desire to do so. Similarly, 24% self-administered medications, but 54% wanted to. The Wilcoxon signed rank test confirmed statistically significant differences (P<0.05) for viewing records and self-administration.

- Patient involvement in medication safety behaviours.
| Behaviour | Actual (%) | Desired (%) | P-value (Wilcoxon) |
|---|---|---|---|
| Viewing medication records | 43 | 79 | <0.05 |
| Selfadministration | 24 | 54 | <0.05 |
| Asking medication questions | 78 | 84 | 0.12 |
| Checking for errors | 35 | 65 | <0.05 |
P value <0.05 was considered as significant.
Healthcare professional support
Figure 2 shows strong healthcare professional support for patient engagement, with 90% or more endorsing behaviours like asking questions, checking for errors, and alerting staff. Support for self-administration was lowest at 65%, with nurses less supportive than doctors (Mann-Whitney U-test, P < 0.05).

- Healthcare professional support for patient engagement.
Comparative views
Differences between patients and healthcare professionals in different aspects of medication are shown in Table 3.
| Comparison | Chisquare | P-value | Mann-Whitney U | P-value | Conclusion |
|---|---|---|---|---|---|
| Viewing of drug chart | 62.35 | <0.0001 | 2800 | <0.0001 | Significant difference |
| Asking questions about their drugs | 53.03 | <0.0001 | 3050 | <0.0001 | Significant difference |
| Prompting administering of forgotten drugs | 41.37 | <0.0001 | 3400 | <0.0001 | Significant difference |
| Alerting to wrong medication | 24.02 | <0.0001 | 3850 | <0.0001 | Significant difference |
| Selfadministration | 35.45 | <0.0001 | 3700 | <0.0001 | Significant difference |
P value less than 0.01 was considered as significant
Figure 3 and Table 3 highlight differences in perspectives, with healthcare professionals more supportive of patient engagement than patients’ reported experiences (Mann-Whitney U-test, Chi-square test, P < 0.0001). This discrepancy may reflect communication gaps, where professionals’ encouragement is not effectively conveyed to patients, potentially due to time constraints or unclear roles.

- Views on involvement between patients and healthcare professionals in different aspects of medication.
Decision-making preferences
Figures 4-6 and Table 4 show both groups favoured shared decision-making for starting (HCPs: 53%, Patients: 48%), dosing (HCPs: 56%, Patients: 43%), and stopping medications (HCPs: 57%, Patients: 43%). Patients leaned more toward doctor-led decisions (e.g., 29% preferred “Mostly Doctor” for starting medications vs. 11% of HCPs; P < 0.01).

- Decision on starting a new medicine.

- Decision on choosing the dose of medicine.

- Decision on stopping a medicine.
| Decision | Group | Shared (%) | Mostly doctor (%) | Doctor alone (%) |
|---|---|---|---|---|
| Starting medication | Patients | 48 | 29 | 15 |
| HCPs | 53 | 11 | 7 | |
| Dosing medication | Patients | 43 | 25 | 20 |
| HCPs | 56 | 12 | 9 | |
| Stopping medication | Patients | 43 | 27 | 18 |
| HCPs | 57 | 10 | 8 |
HCPs: Health care professionals
DISCUSSION
The findings align with prior research emphasizing patient involvement in medication safety. Mohsin-Shaikh et al. reported similar support, noting its potential to enhance safety.[6] The gap between desired and actual engagement suggests systemic barriers, such as lack of encouragement or unclear roles, consistent with Kim et al.[4] Unlike Davis et al., who found patients reluctant to report errors, 78% of patients here asked medication-related questions, indicating a shift toward proactive engagement, possibly influenced by cultural factors like increasing patient autonomy expectations in the study setting.[7] Cultural influences, such as trust in healthcare systems or societal norms around questioning authority, may shape patients’ willingness to engage. This warrants further exploration.
Healthcare professionals’ stronger support (90%+) for behaviours like error-checking aligns with Entwistle et al., who emphasized collaborative environments.[8] Lower support for self-administration (65%), particularly among nurses, may reflect concerns about liability or patient capability, as noted by Cumbler et al.[9] Pedersen et al. suggest self-administration could empower patients if supported by clear protocols.[10] The preference for shared decision-making aligns with Garfield et al.,[11] though patients’ inclination toward doctor-led decisions may stem from trust in expertise or lack of confidence, as Doherty and Stavropoulou observed.[12]
Interventions like structured patient education programs (Kim et al.) and professional training to foster collaboration could bridge the engagement gap.[4] Local observations by McLeod support patients preventing errors through querying, suggesting clear communication channels and access to medication records could enhance engagement.[5] The WHO’s advocacy for patient engagement in safer primary care applies to inpatient settings, though systemic challenges like resource constraints (Aranaz et al.,) must be addressed.[13,14]
Future research could explore digital tools for accessing medication records or training modules for professionals. Comparative studies across healthcare settings could clarify cultural and systemic influences on engagement.
CONCLUSION
This study highlights a shared desire for greater patient involvement in medication safety within a tertiary care teaching hospital. However, systemic barriers and communication gaps hinder progress. Interventions such as patient education, improved access to medication records, and professional training are essential to align actual and desired engagement, enhancing safety and adherence in line with global patient safety goals.
Limitations
The study used convenience sampling and included only patients capable of understanding medication charts, limiting generalizability to broader populations, including those with lower health literacy. Future studies could employ stratified or random sampling to enhance representativeness and include diverse patient groups. The sample size, while sufficient for exploratory analysis, may not fully capture diverse perspectives.
Acknowledgments
The authors express gratitude to survey participants and the data collection team for their contributions.
Ethical approval
The research/study approved by the Institutional Review Board at NIMS, number IRB No. 2024/045, dated 13th June, 2024.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest
There are no conflict of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Conceptual Framework for the International Classification for Patient Safety Geneva: WHO; 2009. Version. 1.1
- [Google Scholar]
- Keeping Patients Safe: Transforming the Work Environment of Nurses Washington, DC: National Academies Press; 2004.
- [Google Scholar]
- Evaluation of Patient and Family Engagement Strategies to Improve Medication Safety. Patient. 2018;11:193-206.
- [CrossRef] [PubMed] [Google Scholar]
- Medication Administration Systems and Safety in the UK NHS [PhD thesis] London: UCL School of Pharmacy; 2013.
- [Google Scholar]
- Patient Involvement in Medication Safety in Hospital: An Exploratory Study. Int J Clin Pharm. 2014;36:657-66.
- [CrossRef] [PubMed] [Google Scholar]
- Patient Involvement in Patient Safety: How Willing are Patients to Participate? BMJ Qual Saf. 2011;20:108-14.
- [CrossRef] [PubMed] [Google Scholar]
- Patients' Perspectives on Safety Participation. BMJ Qual Saf. 2010;19:e33.
- [CrossRef] [PubMed] [Google Scholar]
- Lack of Patient Knowledge Regarding Hospital Medications. J Hosp Med. 2010;5:83-6.
- [CrossRef] [PubMed] [Google Scholar]
- Relationships between Healthcare Users and Providers: Impact on Care Quality London: The Health Foundation; 2013.
- [Google Scholar]
- Can Patients' Preferences for Involvement in Decision-Making Regarding the use of Medicines be Predicted? Patient Educ Couns. 2007;66:361-7.
- [CrossRef] [PubMed] [Google Scholar]
- Patients' Willingness and Ability to Participate Actively in the Reduction of Clinical Errors: A Systematic Literature Review. Soc Sci Med. 2012;75:257-63.
- [CrossRef] [PubMed] [Google Scholar]
- National Study on Adverse Events Related to Hospitalization: ENEAS 2005 Madrid: Ministry of Health and Consumer Affairs; 2006.
- [Google Scholar]

